Compile Data Set for Download or QSAR
Report error Found 427 with Last Name = 'maltais' and Initial = 'f'
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050756(CHEMBL3317977)
Affinity DataKd:  80nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050697(CHEMBL3317982)
Affinity DataKd:  70nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050706(CHEMBL3318002)
Affinity DataKd: <2nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050713(CHEMBL3317987)
Affinity DataKd:  500nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050718(CHEMBL3317969)
Affinity DataKd:  100nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050760(CHEMBL3317981)
Affinity DataKd:  70nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050720(CHEMBL3317972)
Affinity DataKd:  700nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050721(CHEMBL3317973)
Affinity DataKd:  300nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050750(CHEMBL3317975)
Affinity DataKd:  100nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050707(CHEMBL3318003)
Affinity DataKd:  9nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050709(CHEMBL3318005)
Affinity DataKd: <2nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050705(CHEMBL3318001)
Affinity DataKd: <2nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050719(CHEMBL3317970)
Affinity DataKd:  300nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050754(CHEMBL3317976)
Affinity DataKd:  400nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050714(CHEMBL3317988)
Affinity DataKd:  400nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050703(CHEMBL3318000)
Affinity DataKd: <2nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050710(CHEMBL3318006)
Affinity DataKd: <5nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050716(CHEMBL3317990)
Affinity DataKd:  20nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050699(CHEMBL3317984)
Affinity DataKd:  400nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050700(CHEMBL3317985)
Affinity DataKd:  200nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050702(CHEMBL3317999)
Affinity DataKd:  30nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050757(CHEMBL3317978)
Affinity DataKd:  90nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050708(CHEMBL3318004)
Affinity DataKd: <2nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050722(CHEMBL3317974)
Affinity DataKd:  100nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050717(CHEMBL3317991)
Affinity DataKd:  90nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050701(CHEMBL3317986)
Affinity DataKd:  400nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050759(CHEMBL3317980)
Affinity DataKd:  100nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050698(CHEMBL3317983)
Affinity DataKd:  200nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050758(CHEMBL3317979)
Affinity DataKd:  4.90E+3nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetPolymerase basic protein 2(Influenza A virus (strain A/Puerto Rico/8/1934 H1N...)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50050715(CHEMBL3317989)
Affinity DataKd:  400nMAssay Description:Binding affinity to influenza A virus (A/Puerto Rico/8/1934(H1N1)) PB2 by competition binding fluorescence polarization (FP) assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2016
Entry Details Article
PubMed
TargetElongation of very long chain fatty acids protein 1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50581560(CHEMBL5090501)
Affinity DataIC50: 0.300nMAssay Description:Inhibition of ELOVL1 in HEK293 cells assessed as reduction of C26:0 lipo phosphatidyl choline synthesisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetElongation of very long chain fatty acids protein 1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50581564(CHEMBL5092963)
Affinity DataIC50: 0.400nMAssay Description:Inhibition of ELOVL1 in HEK293 cells assessed as reduction of C26:0 lipo phosphatidyl choline synthesisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetElongation of very long chain fatty acids protein 1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50581561(CHEMBL5075747)
Affinity DataIC50: 0.600nMAssay Description:Inhibition of ELOVL1 in HEK293 cells assessed as reduction of C26:0 lipo phosphatidyl choline synthesisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetElongation of very long chain fatty acids protein 1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50581562(CHEMBL5081977)
Affinity DataIC50: 2nMAssay Description:Inhibition of ELOVL1 in HEK293 cells assessed as reduction of C26:0 lipo phosphatidyl choline synthesisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetElongation of very long chain fatty acids protein 1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50581563(CHEMBL5093558)
Affinity DataIC50: 3nMAssay Description:Inhibition of ELOVL1 in HEK293 cells assessed as reduction of C26:0 lipo phosphatidyl choline synthesisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetElongation of very long chain fatty acids protein 1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50581569(CHEMBL5085396)
Affinity DataIC50: 5nMAssay Description:Inhibition of ELOVL1 in HEK293 cells assessed as reduction of C26:0 lipo phosphatidyl choline synthesisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetElongation of very long chain fatty acids protein 1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50596133(CHEMBL5081193)
Affinity DataIC50: 5nMAssay Description:Inhibition of ELOVL1 in Het Female 1 patient-derived human lymphocyte assessed as reduction of C26:0 VLCFA synthesis incubated for 48 hrs by cellular...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetElongation of very long chain fatty acids protein 1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50581566(CHEMBL5079831)
Affinity DataIC50: 7nMAssay Description:Inhibition of ELOVL1 in HEK293 cells assessed as reduction of C26:0 lipo phosphatidyl choline synthesisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetElongation of very long chain fatty acids protein 1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50581565(CHEMBL5091893)
Affinity DataIC50: 7nMAssay Description:Inhibition of ELOVL1 in HEK293 cells assessed as reduction of C26:0 lipo phosphatidyl choline synthesisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetElongation of very long chain fatty acids protein 1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50581567(CHEMBL5088572)
Affinity DataIC50: 7nMAssay Description:Inhibition of ELOVL1 in HEK293 cells assessed as reduction of C26:0 lipo phosphatidyl choline synthesisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetElongation of very long chain fatty acids protein 1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50581570(CHEMBL5082929)
Affinity DataIC50: 9nMAssay Description:Inhibition of ELOVL1 in HEK293 cells assessed as reduction of C26:0 lipo phosphatidyl choline synthesisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetElongation of very long chain fatty acids protein 1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50596133(CHEMBL5081193)
Affinity DataIC50: 9nMAssay Description:Inhibition of ELOVL1 in Het Female 2 patient-derived human lymphocyte assessed as reduction of C26:0 VLCFA synthesis incubated for 48 hrs by cellular...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetElongation of very long chain fatty acids protein 1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50581568(CHEMBL5091423)
Affinity DataIC50: 9nMAssay Description:Inhibition of ELOVL1 in HEK293 cells assessed as reduction of C26:0 lipo phosphatidyl choline synthesisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetElongation of very long chain fatty acids protein 1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50581571(CHEMBL5084780)
Affinity DataIC50: 10nMAssay Description:Inhibition of ELOVL1 in HEK293 cells assessed as reduction of C26:0 lipo phosphatidyl choline synthesisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetElongation of very long chain fatty acids protein 1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50596133(CHEMBL5081193)
Affinity DataIC50: 11nMAssay Description:Inhibition of ELOVL1 in human microglia assessed as reduction of C26:0 VLCFA synthesis incubated for 48 hrs by cellular assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetElongation of very long chain fatty acids protein 1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50596154(CHEMBL5169448)
Affinity DataIC50: 12nMAssay Description:Inhibition of ELOVL1 in human HEK2936E cells assessed as reduction of C26:0 LPC synthesis incubated for 48 hrs by cellular assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetElongation of very long chain fatty acids protein 1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50581572(CHEMBL5084384)
Affinity DataIC50: 12nMAssay Description:Inhibition of ELOVL1 in HEK293 cells assessed as reduction of C26:0 lipo phosphatidyl choline synthesisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetElongation of very long chain fatty acids protein 1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50596133(CHEMBL5081193)
Affinity DataIC50: 13nMAssay Description:Inhibition of ELOVL1 in human HEK2936E cells assessed as reduction of C26:0 LPC synthesis incubated for 48 hrs by cellular assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetElongation of very long chain fatty acids protein 1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50596133(CHEMBL5081193)
Affinity DataIC50: 13nMAssay Description:Inhibition of ELOVL1 in human HEK293 cells assessed as reduction of C26:0 VLCFA synthesis incubated for 48 hrs by cellular assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetElongation of very long chain fatty acids protein 1(Human)
Vertex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50581573(CHEMBL5084868)
Affinity DataIC50: 15nMAssay Description:Inhibition of ELOVL1 in HEK293 cells assessed as reduction of C26:0 lipo phosphatidyl choline synthesisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
Displayed 1 to 50 (of 427 total ) | Next | Last >>
Jump to: